nodes	percent_of_prediction	percent_of_DWPC	metapath
Bromocriptine—CYP1A2—Dacarbazine—sarcoma	0.077	0.162	CbGbCtD
Bromocriptine—CYP3A4—Thiotepa—sarcoma	0.0728	0.153	CbGbCtD
Bromocriptine—ABCB1—Dactinomycin—sarcoma	0.0584	0.123	CbGbCtD
Bromocriptine—ABCB1—Mitoxantrone—sarcoma	0.0522	0.11	CbGbCtD
Bromocriptine—CYP1A2—Etoposide—sarcoma	0.0377	0.0792	CbGbCtD
Bromocriptine—ABCB1—Vincristine—sarcoma	0.0359	0.0756	CbGbCtD
Bromocriptine—HTR1D—meninx—sarcoma	0.0332	0.173	CbGeAlD
Bromocriptine—ABCB1—Etoposide—sarcoma	0.0329	0.0693	CbGbCtD
Bromocriptine—HTR1B—dura mater—sarcoma	0.0315	0.164	CbGeAlD
Bromocriptine—CYP3A4—Mitoxantrone—sarcoma	0.0313	0.0658	CbGbCtD
Bromocriptine—HTR1D—dura mater—sarcoma	0.0305	0.159	CbGeAlD
Bromocriptine—ABCB1—Doxorubicin—sarcoma	0.0225	0.0473	CbGbCtD
Bromocriptine—CYP3A4—Vincristine—sarcoma	0.0215	0.0453	CbGbCtD
Bromocriptine—CYP3A4—Etoposide—sarcoma	0.0197	0.0415	CbGbCtD
Bromocriptine—CYP3A4—Doxorubicin—sarcoma	0.0135	0.0283	CbGbCtD
Bromocriptine—HTR7—pulmonary artery—sarcoma	0.0104	0.0541	CbGeAlD
Bromocriptine—HTR2A—pulmonary artery—sarcoma	0.00647	0.0338	CbGeAlD
Bromocriptine—HTR2A—hindlimb—sarcoma	0.00391	0.0204	CbGeAlD
Bromocriptine—HTR2A—appendage—sarcoma	0.00336	0.0175	CbGeAlD
Bromocriptine—DRD5—hematopoietic system—sarcoma	0.00334	0.0174	CbGeAlD
Bromocriptine—HTR7—endothelium—sarcoma	0.00325	0.017	CbGeAlD
Bromocriptine—DRD4—testis—sarcoma	0.00278	0.0145	CbGeAlD
Bromocriptine—DRD5—lymphoid tissue—sarcoma	0.00235	0.0123	CbGeAlD
Bromocriptine—HTR2B—myometrium—sarcoma	0.00217	0.0113	CbGeAlD
Bromocriptine—HTR2A—endothelium—sarcoma	0.00203	0.0106	CbGeAlD
Bromocriptine—HTR1D—connective tissue—sarcoma	0.00193	0.0101	CbGeAlD
Bromocriptine—ADRB1—connective tissue—sarcoma	0.00187	0.00978	CbGeAlD
Bromocriptine—ADRA2C—myometrium—sarcoma	0.00171	0.00891	CbGeAlD
Bromocriptine—HTR1A—hematopoietic system—sarcoma	0.00167	0.00871	CbGeAlD
Bromocriptine—HTR2B—smooth muscle tissue—sarcoma	0.00164	0.00857	CbGeAlD
Bromocriptine—HTR2B—skin of body—sarcoma	0.00162	0.00845	CbGeAlD
Bromocriptine—HTR7—hematopoietic system—sarcoma	0.0016	0.00833	CbGeAlD
Bromocriptine—ADRA2C—seminal vesicle—sarcoma	0.00154	0.00805	CbGeAlD
Bromocriptine—ADRA1A—hematopoietic system—sarcoma	0.00154	0.00803	CbGeAlD
Bromocriptine—HTR7—connective tissue—sarcoma	0.00154	0.00802	CbGeAlD
Bromocriptine—ADRB1—cardiac atrium—sarcoma	0.00148	0.00771	CbGeAlD
Bromocriptine—HTR2B—uterus—sarcoma	0.00141	0.00735	CbGeAlD
Bromocriptine—HTR7—smooth muscle tissue—sarcoma	0.00141	0.00733	CbGeAlD
Bromocriptine—ADRA2A—myometrium—sarcoma	0.00136	0.00711	CbGeAlD
Bromocriptine—CYP1A2—hematopoietic system—sarcoma	0.00127	0.00664	CbGeAlD
Bromocriptine—HTR2B—tendon—sarcoma	0.00123	0.00644	CbGeAlD
Bromocriptine—ADRA2A—seminal vesicle—sarcoma	0.00123	0.00643	CbGeAlD
Bromocriptine—ADRA2A—hematopoietic system—sarcoma	0.00117	0.00611	CbGeAlD
Bromocriptine—ADRA2A—connective tissue—sarcoma	0.00113	0.00588	CbGeAlD
Bromocriptine—HTR2A—embryo—sarcoma	0.00111	0.00582	CbGeAlD
Bromocriptine—ADRA2C—cardiac atrium—sarcoma	0.00111	0.00581	CbGeAlD
Bromocriptine—ADRA2C—uterus—sarcoma	0.00111	0.00578	CbGeAlD
Bromocriptine—ADRA1A—lymphoid tissue—sarcoma	0.00108	0.00565	CbGeAlD
Bromocriptine—HTR7—tendon—sarcoma	0.00106	0.00551	CbGeAlD
Bromocriptine—HTR2A—hematopoietic system—sarcoma	0.000995	0.00519	CbGeAlD
Bromocriptine—ADRA2C—tendon—sarcoma	0.000971	0.00507	CbGeAlD
Bromocriptine—HTR2A—connective tissue—sarcoma	0.000958	0.005	CbGeAlD
Bromocriptine—CYP3A4—hematopoietic system—sarcoma	0.000921	0.00481	CbGeAlD
Bromocriptine—ADRA2A—cardiac atrium—sarcoma	0.000889	0.00464	CbGeAlD
Bromocriptine—ADRA2A—uterus—sarcoma	0.000884	0.00461	CbGeAlD
Bromocriptine—HTR2A—smooth muscle tissue—sarcoma	0.000876	0.00457	CbGeAlD
Bromocriptine—HTR7—testis—sarcoma	0.000874	0.00456	CbGeAlD
Bromocriptine—DRD2—testis—sarcoma	0.000827	0.00431	CbGeAlD
Bromocriptine—HTR7—liver—sarcoma	0.000827	0.00431	CbGeAlD
Bromocriptine—ADRA2C—testis—sarcoma	0.000804	0.00419	CbGeAlD
Bromocriptine—ADRA1A—liver—sarcoma	0.000797	0.00416	CbGeAlD
Bromocriptine—Decreased appetite—Dactinomycin—sarcoma	0.000791	0.0024	CcSEcCtD
Bromocriptine—Fatigue—Thiotepa—sarcoma	0.00079	0.0024	CcSEcCtD
Bromocriptine—Dysgeusia—Etoposide—sarcoma	0.00079	0.0024	CcSEcCtD
Bromocriptine—Infection—Mitoxantrone—sarcoma	0.000786	0.00239	CcSEcCtD
Bromocriptine—Fatigue—Dactinomycin—sarcoma	0.000784	0.00238	CcSEcCtD
Bromocriptine—Constipation—Thiotepa—sarcoma	0.000784	0.00238	CcSEcCtD
Bromocriptine—Shock—Mitoxantrone—sarcoma	0.000779	0.00237	CcSEcCtD
Bromocriptine—Muscle spasms—Etoposide—sarcoma	0.000776	0.00236	CcSEcCtD
Bromocriptine—Anorexia—Vincristine—sarcoma	0.000775	0.00235	CcSEcCtD
Bromocriptine—ADRA2A—tendon—sarcoma	0.000774	0.00404	CbGeAlD
Bromocriptine—Tachycardia—Mitoxantrone—sarcoma	0.000772	0.00235	CcSEcCtD
Bromocriptine—Hypoglycaemia—Epirubicin—sarcoma	0.000769	0.00234	CcSEcCtD
Bromocriptine—Skin disorder—Mitoxantrone—sarcoma	0.000769	0.00234	CcSEcCtD
Bromocriptine—Lethargy—Epirubicin—sarcoma	0.000766	0.00233	CcSEcCtD
Bromocriptine—Cerebrovascular accident—Epirubicin—sarcoma	0.000766	0.00233	CcSEcCtD
Bromocriptine—Cardiac failure congestive—Doxorubicin—sarcoma	0.000766	0.00233	CcSEcCtD
Bromocriptine—ADRA2C—liver—sarcoma	0.00076	0.00397	CbGeAlD
Bromocriptine—Hypotension—Vincristine—sarcoma	0.000759	0.00231	CcSEcCtD
Bromocriptine—ABCB1—myometrium—sarcoma	0.000759	0.00396	CbGeAlD
Bromocriptine—Feeling abnormal—Thiotepa—sarcoma	0.000755	0.0023	CcSEcCtD
Bromocriptine—Anorexia—Mitoxantrone—sarcoma	0.000754	0.00229	CcSEcCtD
Bromocriptine—Diplopia—Epirubicin—sarcoma	0.000751	0.00228	CcSEcCtD
Bromocriptine—Gastrointestinal haemorrhage—Epirubicin—sarcoma	0.000751	0.00228	CcSEcCtD
Bromocriptine—Feeling abnormal—Dactinomycin—sarcoma	0.00075	0.00228	CcSEcCtD
Bromocriptine—Gastrointestinal pain—Thiotepa—sarcoma	0.000749	0.00228	CcSEcCtD
Bromocriptine—Gastrointestinal pain—Dactinomycin—sarcoma	0.000744	0.00226	CcSEcCtD
Bromocriptine—HTR2B—lymph node—sarcoma	0.00074	0.00386	CbGeAlD
Bromocriptine—Hypotension—Mitoxantrone—sarcoma	0.00074	0.00225	CcSEcCtD
Bromocriptine—Insomnia—Vincristine—sarcoma	0.000735	0.00223	CcSEcCtD
Bromocriptine—ABCB1—embryo—sarcoma	0.00073	0.00381	CbGeAlD
Bromocriptine—Paraesthesia—Vincristine—sarcoma	0.00073	0.00222	CcSEcCtD
Bromocriptine—Urticaria—Thiotepa—sarcoma	0.000728	0.00221	CcSEcCtD
Bromocriptine—Vertigo—Etoposide—sarcoma	0.000725	0.0022	CcSEcCtD
Bromocriptine—Body temperature increased—Thiotepa—sarcoma	0.000725	0.0022	CcSEcCtD
Bromocriptine—Abdominal pain—Thiotepa—sarcoma	0.000725	0.0022	CcSEcCtD
Bromocriptine—Body temperature increased—Dactinomycin—sarcoma	0.000719	0.00219	CcSEcCtD
Bromocriptine—Abdominal pain—Dactinomycin—sarcoma	0.000719	0.00219	CcSEcCtD
Bromocriptine—Hypoglycaemia—Doxorubicin—sarcoma	0.000712	0.00216	CcSEcCtD
Bromocriptine—Paraesthesia—Mitoxantrone—sarcoma	0.000711	0.00216	CcSEcCtD
Bromocriptine—Loss of consciousness—Etoposide—sarcoma	0.000709	0.00216	CcSEcCtD
Bromocriptine—Lethargy—Doxorubicin—sarcoma	0.000709	0.00216	CcSEcCtD
Bromocriptine—Cerebrovascular accident—Doxorubicin—sarcoma	0.000709	0.00216	CcSEcCtD
Bromocriptine—Decreased appetite—Vincristine—sarcoma	0.000707	0.00215	CcSEcCtD
Bromocriptine—Ataxia—Epirubicin—sarcoma	0.000706	0.00215	CcSEcCtD
Bromocriptine—Dyspnoea—Mitoxantrone—sarcoma	0.000706	0.00215	CcSEcCtD
Bromocriptine—Somnolence—Mitoxantrone—sarcoma	0.000704	0.00214	CcSEcCtD
Bromocriptine—Gastrointestinal disorder—Vincristine—sarcoma	0.000702	0.00213	CcSEcCtD
Bromocriptine—Fatigue—Vincristine—sarcoma	0.000701	0.00213	CcSEcCtD
Bromocriptine—Convulsion—Etoposide—sarcoma	0.000699	0.00212	CcSEcCtD
Bromocriptine—Dyspepsia—Mitoxantrone—sarcoma	0.000697	0.00212	CcSEcCtD
Bromocriptine—Hypertension—Etoposide—sarcoma	0.000696	0.00212	CcSEcCtD
Bromocriptine—Constipation—Vincristine—sarcoma	0.000695	0.00211	CcSEcCtD
Bromocriptine—Diplopia—Doxorubicin—sarcoma	0.000695	0.00211	CcSEcCtD
Bromocriptine—Gastrointestinal haemorrhage—Doxorubicin—sarcoma	0.000695	0.00211	CcSEcCtD
Bromocriptine—Decreased appetite—Mitoxantrone—sarcoma	0.000688	0.00209	CcSEcCtD
Bromocriptine—ABCB1—seminal vesicle—sarcoma	0.000686	0.00358	CbGeAlD
Bromocriptine—Orthostatic hypotension—Epirubicin—sarcoma	0.000686	0.00208	CcSEcCtD
Bromocriptine—Abdominal pain upper—Epirubicin—sarcoma	0.000686	0.00208	CcSEcCtD
Bromocriptine—Fatigue—Mitoxantrone—sarcoma	0.000682	0.00207	CcSEcCtD
Bromocriptine—Unspecified disorder of skin and subcutaneous tissue—Etoposide—sarcoma	0.000682	0.00207	CcSEcCtD
Bromocriptine—Constipation—Mitoxantrone—sarcoma	0.000677	0.00206	CcSEcCtD
Bromocriptine—Nasopharyngitis—Epirubicin—sarcoma	0.000671	0.00204	CcSEcCtD
Bromocriptine—Gastrointestinal pain—Vincristine—sarcoma	0.000665	0.00202	CcSEcCtD
Bromocriptine—Confusional state—Etoposide—sarcoma	0.000664	0.00202	CcSEcCtD
Bromocriptine—CYP1A2—liver—sarcoma	0.000659	0.00344	CbGeAlD
Bromocriptine—HTR2A—tendon—sarcoma	0.000659	0.00344	CbGeAlD
Bromocriptine—Asthenia—Thiotepa—sarcoma	0.000658	0.002	CcSEcCtD
Bromocriptine—Infection—Etoposide—sarcoma	0.000654	0.00199	CcSEcCtD
Bromocriptine—Ataxia—Doxorubicin—sarcoma	0.000653	0.00199	CcSEcCtD
Bromocriptine—Asthenia—Dactinomycin—sarcoma	0.000653	0.00198	CcSEcCtD
Bromocriptine—Feeling abnormal—Mitoxantrone—sarcoma	0.000652	0.00198	CcSEcCtD
Bromocriptine—ABCB1—hematopoietic system—sarcoma	0.000652	0.0034	CbGeAlD
Bromocriptine—Influenza—Epirubicin—sarcoma	0.000649	0.00197	CcSEcCtD
Bromocriptine—Dysphagia—Epirubicin—sarcoma	0.000649	0.00197	CcSEcCtD
Bromocriptine—Gastrointestinal pain—Mitoxantrone—sarcoma	0.000647	0.00197	CcSEcCtD
Bromocriptine—Tachycardia—Etoposide—sarcoma	0.000643	0.00195	CcSEcCtD
Bromocriptine—Abdominal pain—Vincristine—sarcoma	0.000642	0.00195	CcSEcCtD
Bromocriptine—Body temperature increased—Vincristine—sarcoma	0.000642	0.00195	CcSEcCtD
Bromocriptine—ADRA2A—testis—sarcoma	0.000641	0.00335	CbGeAlD
Bromocriptine—Skin disorder—Etoposide—sarcoma	0.000639	0.00194	CcSEcCtD
Bromocriptine—Orthostatic hypotension—Doxorubicin—sarcoma	0.000635	0.00193	CcSEcCtD
Bromocriptine—Abdominal pain upper—Doxorubicin—sarcoma	0.000635	0.00193	CcSEcCtD
Bromocriptine—Urticaria—Mitoxantrone—sarcoma	0.000629	0.00191	CcSEcCtD
Bromocriptine—Anorexia—Etoposide—sarcoma	0.000628	0.00191	CcSEcCtD
Bromocriptine—Diarrhoea—Thiotepa—sarcoma	0.000627	0.00191	CcSEcCtD
Bromocriptine—Body temperature increased—Mitoxantrone—sarcoma	0.000626	0.0019	CcSEcCtD
Bromocriptine—Abdominal pain—Mitoxantrone—sarcoma	0.000626	0.0019	CcSEcCtD
Bromocriptine—Diarrhoea—Dactinomycin—sarcoma	0.000622	0.00189	CcSEcCtD
Bromocriptine—Nasopharyngitis—Doxorubicin—sarcoma	0.000621	0.00189	CcSEcCtD
Bromocriptine—Hypotension—Etoposide—sarcoma	0.000615	0.00187	CcSEcCtD
Bromocriptine—Dizziness—Thiotepa—sarcoma	0.000606	0.00184	CcSEcCtD
Bromocriptine—Dysphagia—Doxorubicin—sarcoma	0.0006	0.00183	CcSEcCtD
Bromocriptine—Influenza—Doxorubicin—sarcoma	0.0006	0.00183	CcSEcCtD
Bromocriptine—Pollakiuria—Epirubicin—sarcoma	0.0006	0.00182	CcSEcCtD
Bromocriptine—Paraesthesia—Etoposide—sarcoma	0.000591	0.0018	CcSEcCtD
Bromocriptine—Dyspnoea—Etoposide—sarcoma	0.000587	0.00178	CcSEcCtD
Bromocriptine—Somnolence—Etoposide—sarcoma	0.000585	0.00178	CcSEcCtD
Bromocriptine—Asthenia—Vincristine—sarcoma	0.000583	0.00177	CcSEcCtD
Bromocriptine—Vomiting—Thiotepa—sarcoma	0.000583	0.00177	CcSEcCtD
Bromocriptine—ADRA2C—lymph node—sarcoma	0.000583	0.00304	CbGeAlD
Bromocriptine—Drowsiness—Epirubicin—sarcoma	0.000579	0.00176	CcSEcCtD
Bromocriptine—Vomiting—Dactinomycin—sarcoma	0.000578	0.00176	CcSEcCtD
Bromocriptine—Rash—Thiotepa—sarcoma	0.000578	0.00176	CcSEcCtD
Bromocriptine—Dermatitis—Thiotepa—sarcoma	0.000577	0.00176	CcSEcCtD
Bromocriptine—Headache—Thiotepa—sarcoma	0.000574	0.00175	CcSEcCtD
Bromocriptine—Rash—Dactinomycin—sarcoma	0.000574	0.00174	CcSEcCtD
Bromocriptine—Decreased appetite—Etoposide—sarcoma	0.000572	0.00174	CcSEcCtD
Bromocriptine—Gastrointestinal disorder—Etoposide—sarcoma	0.000568	0.00173	CcSEcCtD
Bromocriptine—Asthenia—Mitoxantrone—sarcoma	0.000568	0.00173	CcSEcCtD
Bromocriptine—Fatigue—Etoposide—sarcoma	0.000568	0.00173	CcSEcCtD
Bromocriptine—Constipation—Etoposide—sarcoma	0.000563	0.00171	CcSEcCtD
Bromocriptine—Diarrhoea—Vincristine—sarcoma	0.000556	0.00169	CcSEcCtD
Bromocriptine—Pollakiuria—Doxorubicin—sarcoma	0.000555	0.00169	CcSEcCtD
Bromocriptine—HTR2A—testis—sarcoma	0.000545	0.00285	CbGeAlD
Bromocriptine—Nausea—Thiotepa—sarcoma	0.000544	0.00165	CcSEcCtD
Bromocriptine—Sinusitis—Epirubicin—sarcoma	0.000543	0.00165	CcSEcCtD
Bromocriptine—Feeling abnormal—Etoposide—sarcoma	0.000543	0.00165	CcSEcCtD
Bromocriptine—Diarrhoea—Mitoxantrone—sarcoma	0.000542	0.00165	CcSEcCtD
Bromocriptine—Nausea—Dactinomycin—sarcoma	0.00054	0.00164	CcSEcCtD
Bromocriptine—Gastrointestinal pain—Etoposide—sarcoma	0.000538	0.00164	CcSEcCtD
Bromocriptine—Dizziness—Vincristine—sarcoma	0.000537	0.00163	CcSEcCtD
Bromocriptine—Drowsiness—Doxorubicin—sarcoma	0.000535	0.00163	CcSEcCtD
Bromocriptine—Bradycardia—Epirubicin—sarcoma	0.000529	0.00161	CcSEcCtD
Bromocriptine—Urticaria—Etoposide—sarcoma	0.000523	0.00159	CcSEcCtD
Bromocriptine—Rhinitis—Epirubicin—sarcoma	0.000521	0.00158	CcSEcCtD
Bromocriptine—Body temperature increased—Etoposide—sarcoma	0.00052	0.00158	CcSEcCtD
Bromocriptine—Abdominal pain—Etoposide—sarcoma	0.00052	0.00158	CcSEcCtD
Bromocriptine—Hypoaesthesia—Epirubicin—sarcoma	0.000517	0.00157	CcSEcCtD
Bromocriptine—Vomiting—Vincristine—sarcoma	0.000517	0.00157	CcSEcCtD
Bromocriptine—HTR2A—liver—sarcoma	0.000516	0.00269	CbGeAlD
Bromocriptine—Rash—Vincristine—sarcoma	0.000512	0.00156	CcSEcCtD
Bromocriptine—Dermatitis—Vincristine—sarcoma	0.000512	0.00156	CcSEcCtD
Bromocriptine—Oedema peripheral—Epirubicin—sarcoma	0.000512	0.00156	CcSEcCtD
Bromocriptine—Connective tissue disorder—Epirubicin—sarcoma	0.00051	0.00155	CcSEcCtD
Bromocriptine—Headache—Vincristine—sarcoma	0.000509	0.00155	CcSEcCtD
Bromocriptine—Vomiting—Mitoxantrone—sarcoma	0.000503	0.00153	CcSEcCtD
Bromocriptine—Sinusitis—Doxorubicin—sarcoma	0.000502	0.00153	CcSEcCtD
Bromocriptine—Visual impairment—Epirubicin—sarcoma	0.000501	0.00152	CcSEcCtD
Bromocriptine—Rash—Mitoxantrone—sarcoma	0.000499	0.00152	CcSEcCtD
Bromocriptine—Dermatitis—Mitoxantrone—sarcoma	0.000499	0.00152	CcSEcCtD
Bromocriptine—Headache—Mitoxantrone—sarcoma	0.000496	0.00151	CcSEcCtD
Bromocriptine—ABCB1—uterus—sarcoma	0.000493	0.00257	CbGeAlD
Bromocriptine—Bradycardia—Doxorubicin—sarcoma	0.000489	0.00149	CcSEcCtD
Bromocriptine—Eye disorder—Epirubicin—sarcoma	0.000485	0.00148	CcSEcCtD
Bromocriptine—Tinnitus—Epirubicin—sarcoma	0.000484	0.00147	CcSEcCtD
Bromocriptine—Nausea—Vincristine—sarcoma	0.000483	0.00147	CcSEcCtD
Bromocriptine—Cardiac disorder—Epirubicin—sarcoma	0.000482	0.00147	CcSEcCtD
Bromocriptine—Rhinitis—Doxorubicin—sarcoma	0.000482	0.00146	CcSEcCtD
Bromocriptine—Hypoaesthesia—Doxorubicin—sarcoma	0.000478	0.00145	CcSEcCtD
Bromocriptine—CYP3A4—liver—sarcoma	0.000477	0.00249	CbGeAlD
Bromocriptine—Oedema peripheral—Doxorubicin—sarcoma	0.000473	0.00144	CcSEcCtD
Bromocriptine—Asthenia—Etoposide—sarcoma	0.000472	0.00144	CcSEcCtD
Bromocriptine—Connective tissue disorder—Doxorubicin—sarcoma	0.000472	0.00144	CcSEcCtD
Bromocriptine—Angiopathy—Epirubicin—sarcoma	0.000471	0.00143	CcSEcCtD
Bromocriptine—Nausea—Mitoxantrone—sarcoma	0.00047	0.00143	CcSEcCtD
Bromocriptine—Mediastinal disorder—Epirubicin—sarcoma	0.000468	0.00142	CcSEcCtD
Bromocriptine—ADRA2A—lymph node—sarcoma	0.000465	0.00243	CbGeAlD
Bromocriptine—Arrhythmia—Epirubicin—sarcoma	0.000464	0.00141	CcSEcCtD
Bromocriptine—Visual impairment—Doxorubicin—sarcoma	0.000463	0.00141	CcSEcCtD
Bromocriptine—ABCB1—lymphoid tissue—sarcoma	0.000459	0.0024	CbGeAlD
Bromocriptine—Alopecia—Epirubicin—sarcoma	0.000459	0.0014	CcSEcCtD
Bromocriptine—Mental disorder—Epirubicin—sarcoma	0.000455	0.00138	CcSEcCtD
Bromocriptine—Diarrhoea—Etoposide—sarcoma	0.00045	0.00137	CcSEcCtD
Bromocriptine—Eye disorder—Doxorubicin—sarcoma	0.000449	0.00137	CcSEcCtD
Bromocriptine—Tinnitus—Doxorubicin—sarcoma	0.000448	0.00136	CcSEcCtD
Bromocriptine—Cardiac disorder—Doxorubicin—sarcoma	0.000446	0.00136	CcSEcCtD
Bromocriptine—Tension—Epirubicin—sarcoma	0.000444	0.00135	CcSEcCtD
Bromocriptine—Dysgeusia—Epirubicin—sarcoma	0.000443	0.00135	CcSEcCtD
Bromocriptine—Nervousness—Epirubicin—sarcoma	0.000439	0.00134	CcSEcCtD
Bromocriptine—Angiopathy—Doxorubicin—sarcoma	0.000436	0.00133	CcSEcCtD
Bromocriptine—Dizziness—Etoposide—sarcoma	0.000435	0.00132	CcSEcCtD
Bromocriptine—Muscle spasms—Epirubicin—sarcoma	0.000435	0.00132	CcSEcCtD
Bromocriptine—Mediastinal disorder—Doxorubicin—sarcoma	0.000433	0.00132	CcSEcCtD
Bromocriptine—Arrhythmia—Doxorubicin—sarcoma	0.000429	0.00131	CcSEcCtD
Bromocriptine—Vision blurred—Epirubicin—sarcoma	0.000426	0.0013	CcSEcCtD
Bromocriptine—Alopecia—Doxorubicin—sarcoma	0.000425	0.00129	CcSEcCtD
Bromocriptine—Mental disorder—Doxorubicin—sarcoma	0.000421	0.00128	CcSEcCtD
Bromocriptine—Vomiting—Etoposide—sarcoma	0.000419	0.00127	CcSEcCtD
Bromocriptine—ABCB1—bone marrow—sarcoma	0.000418	0.00218	CbGeAlD
Bromocriptine—Agitation—Epirubicin—sarcoma	0.000416	0.00126	CcSEcCtD
Bromocriptine—Rash—Etoposide—sarcoma	0.000415	0.00126	CcSEcCtD
Bromocriptine—Dermatitis—Etoposide—sarcoma	0.000415	0.00126	CcSEcCtD
Bromocriptine—Headache—Etoposide—sarcoma	0.000412	0.00125	CcSEcCtD
Bromocriptine—Tension—Doxorubicin—sarcoma	0.000411	0.00125	CcSEcCtD
Bromocriptine—Dysgeusia—Doxorubicin—sarcoma	0.00041	0.00125	CcSEcCtD
Bromocriptine—Nervousness—Doxorubicin—sarcoma	0.000406	0.00124	CcSEcCtD
Bromocriptine—Vertigo—Epirubicin—sarcoma	0.000406	0.00123	CcSEcCtD
Bromocriptine—Syncope—Epirubicin—sarcoma	0.000406	0.00123	CcSEcCtD
Bromocriptine—Muscle spasms—Doxorubicin—sarcoma	0.000402	0.00122	CcSEcCtD
Bromocriptine—Loss of consciousness—Epirubicin—sarcoma	0.000397	0.00121	CcSEcCtD
Bromocriptine—Vision blurred—Doxorubicin—sarcoma	0.000394	0.0012	CcSEcCtD
Bromocriptine—Convulsion—Epirubicin—sarcoma	0.000392	0.00119	CcSEcCtD
Bromocriptine—Nausea—Etoposide—sarcoma	0.000391	0.00119	CcSEcCtD
Bromocriptine—Hypertension—Epirubicin—sarcoma	0.00039	0.00119	CcSEcCtD
Bromocriptine—Agitation—Doxorubicin—sarcoma	0.000384	0.00117	CcSEcCtD
Bromocriptine—Anxiety—Epirubicin—sarcoma	0.000384	0.00117	CcSEcCtD
Bromocriptine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—sarcoma	0.000382	0.00116	CcSEcCtD
Bromocriptine—Dry mouth—Epirubicin—sarcoma	0.000377	0.00114	CcSEcCtD
Bromocriptine—Vertigo—Doxorubicin—sarcoma	0.000376	0.00114	CcSEcCtD
Bromocriptine—Syncope—Doxorubicin—sarcoma	0.000375	0.00114	CcSEcCtD
Bromocriptine—Confusional state—Epirubicin—sarcoma	0.000372	0.00113	CcSEcCtD
Bromocriptine—Oedema—Epirubicin—sarcoma	0.000369	0.00112	CcSEcCtD
Bromocriptine—Loss of consciousness—Doxorubicin—sarcoma	0.000368	0.00112	CcSEcCtD
Bromocriptine—Infection—Epirubicin—sarcoma	0.000367	0.00111	CcSEcCtD
Bromocriptine—Shock—Epirubicin—sarcoma	0.000363	0.0011	CcSEcCtD
Bromocriptine—Convulsion—Doxorubicin—sarcoma	0.000363	0.0011	CcSEcCtD
Bromocriptine—Nervous system disorder—Epirubicin—sarcoma	0.000362	0.0011	CcSEcCtD
Bromocriptine—Hypertension—Doxorubicin—sarcoma	0.000361	0.0011	CcSEcCtD
Bromocriptine—Tachycardia—Epirubicin—sarcoma	0.00036	0.00109	CcSEcCtD
Bromocriptine—Skin disorder—Epirubicin—sarcoma	0.000358	0.00109	CcSEcCtD
Bromocriptine—ABCB1—testis—sarcoma	0.000357	0.00186	CbGeAlD
Bromocriptine—Anxiety—Doxorubicin—sarcoma	0.000355	0.00108	CcSEcCtD
Bromocriptine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—sarcoma	0.000354	0.00108	CcSEcCtD
Bromocriptine—Anorexia—Epirubicin—sarcoma	0.000352	0.00107	CcSEcCtD
Bromocriptine—Dry mouth—Doxorubicin—sarcoma	0.000348	0.00106	CcSEcCtD
Bromocriptine—Hypotension—Epirubicin—sarcoma	0.000345	0.00105	CcSEcCtD
Bromocriptine—Confusional state—Doxorubicin—sarcoma	0.000344	0.00105	CcSEcCtD
Bromocriptine—Oedema—Doxorubicin—sarcoma	0.000341	0.00104	CcSEcCtD
Bromocriptine—Infection—Doxorubicin—sarcoma	0.000339	0.00103	CcSEcCtD
Bromocriptine—ABCB1—liver—sarcoma	0.000338	0.00176	CbGeAlD
Bromocriptine—Shock—Doxorubicin—sarcoma	0.000336	0.00102	CcSEcCtD
Bromocriptine—Nervous system disorder—Doxorubicin—sarcoma	0.000335	0.00102	CcSEcCtD
Bromocriptine—Insomnia—Epirubicin—sarcoma	0.000334	0.00101	CcSEcCtD
Bromocriptine—Tachycardia—Doxorubicin—sarcoma	0.000333	0.00101	CcSEcCtD
Bromocriptine—Skin disorder—Doxorubicin—sarcoma	0.000332	0.00101	CcSEcCtD
Bromocriptine—Paraesthesia—Epirubicin—sarcoma	0.000331	0.00101	CcSEcCtD
Bromocriptine—Dyspnoea—Epirubicin—sarcoma	0.000329	0.001	CcSEcCtD
Bromocriptine—Somnolence—Epirubicin—sarcoma	0.000328	0.000997	CcSEcCtD
Bromocriptine—Anorexia—Doxorubicin—sarcoma	0.000325	0.000989	CcSEcCtD
Bromocriptine—Dyspepsia—Epirubicin—sarcoma	0.000325	0.000987	CcSEcCtD
Bromocriptine—Decreased appetite—Epirubicin—sarcoma	0.000321	0.000975	CcSEcCtD
Bromocriptine—Hypotension—Doxorubicin—sarcoma	0.000319	0.00097	CcSEcCtD
Bromocriptine—Gastrointestinal disorder—Epirubicin—sarcoma	0.000319	0.000969	CcSEcCtD
Bromocriptine—Fatigue—Epirubicin—sarcoma	0.000318	0.000967	CcSEcCtD
Bromocriptine—Constipation—Epirubicin—sarcoma	0.000316	0.000959	CcSEcCtD
Bromocriptine—Insomnia—Doxorubicin—sarcoma	0.000309	0.000939	CcSEcCtD
Bromocriptine—Paraesthesia—Doxorubicin—sarcoma	0.000307	0.000932	CcSEcCtD
Bromocriptine—Dyspnoea—Doxorubicin—sarcoma	0.000304	0.000925	CcSEcCtD
Bromocriptine—Feeling abnormal—Epirubicin—sarcoma	0.000304	0.000924	CcSEcCtD
Bromocriptine—Somnolence—Doxorubicin—sarcoma	0.000304	0.000923	CcSEcCtD
Bromocriptine—Gastrointestinal pain—Epirubicin—sarcoma	0.000302	0.000917	CcSEcCtD
Bromocriptine—Dyspepsia—Doxorubicin—sarcoma	0.000301	0.000914	CcSEcCtD
Bromocriptine—Decreased appetite—Doxorubicin—sarcoma	0.000297	0.000902	CcSEcCtD
Bromocriptine—Gastrointestinal disorder—Doxorubicin—sarcoma	0.000295	0.000896	CcSEcCtD
Bromocriptine—Fatigue—Doxorubicin—sarcoma	0.000294	0.000895	CcSEcCtD
Bromocriptine—Urticaria—Epirubicin—sarcoma	0.000293	0.000891	CcSEcCtD
Bromocriptine—Constipation—Doxorubicin—sarcoma	0.000292	0.000888	CcSEcCtD
Bromocriptine—Body temperature increased—Epirubicin—sarcoma	0.000292	0.000887	CcSEcCtD
Bromocriptine—Abdominal pain—Epirubicin—sarcoma	0.000292	0.000887	CcSEcCtD
Bromocriptine—Feeling abnormal—Doxorubicin—sarcoma	0.000281	0.000855	CcSEcCtD
Bromocriptine—Gastrointestinal pain—Doxorubicin—sarcoma	0.000279	0.000849	CcSEcCtD
Bromocriptine—Urticaria—Doxorubicin—sarcoma	0.000271	0.000825	CcSEcCtD
Bromocriptine—Abdominal pain—Doxorubicin—sarcoma	0.00027	0.000821	CcSEcCtD
Bromocriptine—Body temperature increased—Doxorubicin—sarcoma	0.00027	0.000821	CcSEcCtD
Bromocriptine—Asthenia—Epirubicin—sarcoma	0.000265	0.000805	CcSEcCtD
Bromocriptine—ABCB1—lymph node—sarcoma	0.000259	0.00135	CbGeAlD
Bromocriptine—Diarrhoea—Epirubicin—sarcoma	0.000253	0.000768	CcSEcCtD
Bromocriptine—Asthenia—Doxorubicin—sarcoma	0.000245	0.000745	CcSEcCtD
Bromocriptine—Dizziness—Epirubicin—sarcoma	0.000244	0.000742	CcSEcCtD
Bromocriptine—Vomiting—Epirubicin—sarcoma	0.000235	0.000713	CcSEcCtD
Bromocriptine—Diarrhoea—Doxorubicin—sarcoma	0.000234	0.00071	CcSEcCtD
Bromocriptine—Rash—Epirubicin—sarcoma	0.000233	0.000707	CcSEcCtD
Bromocriptine—Dermatitis—Epirubicin—sarcoma	0.000232	0.000707	CcSEcCtD
Bromocriptine—Headache—Epirubicin—sarcoma	0.000231	0.000703	CcSEcCtD
Bromocriptine—Dizziness—Doxorubicin—sarcoma	0.000226	0.000686	CcSEcCtD
Bromocriptine—Nausea—Epirubicin—sarcoma	0.000219	0.000666	CcSEcCtD
Bromocriptine—Vomiting—Doxorubicin—sarcoma	0.000217	0.00066	CcSEcCtD
Bromocriptine—Rash—Doxorubicin—sarcoma	0.000215	0.000654	CcSEcCtD
Bromocriptine—Dermatitis—Doxorubicin—sarcoma	0.000215	0.000654	CcSEcCtD
Bromocriptine—Headache—Doxorubicin—sarcoma	0.000214	0.00065	CcSEcCtD
Bromocriptine—Nausea—Doxorubicin—sarcoma	0.000203	0.000617	CcSEcCtD
Bromocriptine—HTR2B—Signaling Pathways—CCND1—sarcoma	1.11e-06	0.00027	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—KIT—sarcoma	1.11e-06	0.00027	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling by GPCR—NRAS—sarcoma	1.11e-06	0.00027	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling Pathways—JUN—sarcoma	1.11e-06	0.000269	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling by GPCR—HRAS—sarcoma	1.11e-06	0.000268	CbGpPWpGaD
Bromocriptine—DRD3—Signaling by GPCR—HRAS—sarcoma	1.11e-06	0.000268	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling Pathways—CTNNB1—sarcoma	1.1e-06	0.000267	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—CREB1—sarcoma	1.1e-06	0.000266	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling by GPCR—KRAS—sarcoma	1.1e-06	0.000266	CbGpPWpGaD
Bromocriptine—HTR6—Signaling Pathways—SRC—sarcoma	1.09e-06	0.000264	CbGpPWpGaD
Bromocriptine—HTR7—Signaling Pathways—SRC—sarcoma	1.09e-06	0.000264	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—MDM2—sarcoma	1.08e-06	0.000263	CbGpPWpGaD
Bromocriptine—HTR1D—Signaling Pathways—SRC—sarcoma	1.08e-06	0.000262	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—CREB1—sarcoma	1.08e-06	0.000262	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling by GPCR—KRAS—sarcoma	1.08e-06	0.000261	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—IL2—sarcoma	1.08e-06	0.000261	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—MDM2—sarcoma	1.07e-06	0.00026	CbGpPWpGaD
Bromocriptine—HTR6—Signaling Pathways—VEGFA—sarcoma	1.06e-06	0.000258	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—IL2—sarcoma	1.06e-06	0.000257	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—IL2—sarcoma	1.06e-06	0.000257	CbGpPWpGaD
Bromocriptine—HTR7—Signaling Pathways—VEGFA—sarcoma	1.06e-06	0.000257	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling Pathways—SRC—sarcoma	1.06e-06	0.000257	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—CREB1—sarcoma	1.06e-06	0.000257	CbGpPWpGaD
Bromocriptine—HTR1D—Signaling Pathways—VEGFA—sarcoma	1.06e-06	0.000256	CbGpPWpGaD
Bromocriptine—DRD2—Signaling by GPCR—EGFR—sarcoma	1.05e-06	0.000255	CbGpPWpGaD
Bromocriptine—HTR6—Signaling Pathways—NRAS—sarcoma	1.05e-06	0.000254	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—CCND1—sarcoma	1.05e-06	0.000254	CbGpPWpGaD
Bromocriptine—HTR7—Signaling Pathways—NRAS—sarcoma	1.05e-06	0.000254	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—JUN—sarcoma	1.05e-06	0.000254	CbGpPWpGaD
Bromocriptine—DRD4—Signaling Pathways—SRC—sarcoma	1.04e-06	0.000253	CbGpPWpGaD
Bromocriptine—HTR1D—Signaling Pathways—NRAS—sarcoma	1.04e-06	0.000253	CbGpPWpGaD
Bromocriptine—DRD5—Signaling Pathways—TP53—sarcoma	1.04e-06	0.000252	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—CTNNB1—sarcoma	1.04e-06	0.000252	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—MDM2—sarcoma	1.04e-06	0.000251	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—CCND1—sarcoma	1.04e-06	0.000251	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—CCND1—sarcoma	1.04e-06	0.000251	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling by GPCR—EGFR—sarcoma	1.04e-06	0.000251	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—KIT—sarcoma	1.03e-06	0.000251	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling by GPCR—NRAS—sarcoma	1.03e-06	0.000251	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—JUN—sarcoma	1.03e-06	0.00025	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—JUN—sarcoma	1.03e-06	0.00025	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling Pathways—VEGFA—sarcoma	1.03e-06	0.00025	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—MDM2—sarcoma	1.03e-06	0.00025	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—CTNNB1—sarcoma	1.03e-06	0.000249	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—CTNNB1—sarcoma	1.03e-06	0.000249	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling Pathways—NRAS—sarcoma	1.02e-06	0.000247	CbGpPWpGaD
Bromocriptine—DRD4—Signaling Pathways—VEGFA—sarcoma	1.02e-06	0.000246	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling by GPCR—EGFR—sarcoma	1.01e-06	0.000246	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling by GPCR—HRAS—sarcoma	1.01e-06	0.000244	CbGpPWpGaD
Bromocriptine—DRD4—Signaling Pathways—NRAS—sarcoma	1e-06	0.000243	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—MDM2—sarcoma	1e-06	0.000243	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling by GPCR—HRAS—sarcoma	9.98e-07	0.000242	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling Pathways—SRC—sarcoma	9.97e-07	0.000241	CbGpPWpGaD
Bromocriptine—DRD5—Signaling Pathways—HRAS—sarcoma	9.96e-07	0.000241	CbGpPWpGaD
Bromocriptine—DRD2—Signaling by GPCR—KRAS—sarcoma	9.95e-07	0.000241	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—MDM2—sarcoma	9.87e-07	0.000239	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—CREB1—sarcoma	9.85e-07	0.000239	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling by GPCR—KRAS—sarcoma	9.79e-07	0.000237	CbGpPWpGaD
Bromocriptine—HTR6—Signaling Pathways—MYC—sarcoma	9.79e-07	0.000237	CbGpPWpGaD
Bromocriptine—HTR7—Signaling Pathways—MYC—sarcoma	9.78e-07	0.000237	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—PLCG1—sarcoma	9.75e-07	0.000236	CbGpPWpGaD
Bromocriptine—HTR1D—Signaling Pathways—MYC—sarcoma	9.71e-07	0.000235	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling Pathways—VEGFA—sarcoma	9.71e-07	0.000235	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—IL2—sarcoma	9.69e-07	0.000235	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling by GPCR—HRAS—sarcoma	9.63e-07	0.000233	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—IL2—sarcoma	9.6e-07	0.000232	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling Pathways—NRAS—sarcoma	9.59e-07	0.000232	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling by GPCR—KRAS—sarcoma	9.59e-07	0.000232	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling by GPCR—HRAS—sarcoma	9.58e-07	0.000232	CbGpPWpGaD
Bromocriptine—HTR6—Signaling Pathways—EGFR—sarcoma	9.57e-07	0.000232	CbGpPWpGaD
Bromocriptine—HTR7—Signaling Pathways—EGFR—sarcoma	9.56e-07	0.000232	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling Pathways—MYC—sarcoma	9.51e-07	0.00023	CbGpPWpGaD
Bromocriptine—HTR1D—Signaling Pathways—EGFR—sarcoma	9.5e-07	0.00023	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—CCND1—sarcoma	9.44e-07	0.000229	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling by GPCR—EGFR—sarcoma	9.43e-07	0.000228	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—JUN—sarcoma	9.42e-07	0.000228	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—SRC—sarcoma	9.4e-07	0.000228	CbGpPWpGaD
Bromocriptine—DRD4—Signaling Pathways—MYC—sarcoma	9.36e-07	0.000227	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—CCND1—sarcoma	9.36e-07	0.000227	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—CTNNB1—sarcoma	9.35e-07	0.000226	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—JUN—sarcoma	9.34e-07	0.000226	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling by GPCR—HRAS—sarcoma	9.32e-07	0.000226	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling Pathways—EGFR—sarcoma	9.3e-07	0.000225	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—SRC—sarcoma	9.28e-07	0.000225	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—SRC—sarcoma	9.28e-07	0.000225	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—CTNNB1—sarcoma	9.27e-07	0.000224	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—IL2—sarcoma	9.26e-07	0.000224	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—IL2—sarcoma	9.22e-07	0.000223	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling by GPCR—HRAS—sarcoma	9.17e-07	0.000222	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—VEGFA—sarcoma	9.16e-07	0.000222	CbGpPWpGaD
Bromocriptine—DRD4—Signaling Pathways—EGFR—sarcoma	9.15e-07	0.000222	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—MDM2—sarcoma	9.1e-07	0.00022	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—NRAS—sarcoma	9.04e-07	0.000219	CbGpPWpGaD
Bromocriptine—HTR6—Signaling Pathways—KRAS—sarcoma	9.04e-07	0.000219	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—VEGFA—sarcoma	9.03e-07	0.000219	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—VEGFA—sarcoma	9.03e-07	0.000219	CbGpPWpGaD
Bromocriptine—HTR7—Signaling Pathways—KRAS—sarcoma	9.03e-07	0.000219	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—CCND1—sarcoma	9.03e-07	0.000219	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—JUN—sarcoma	9.01e-07	0.000218	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—CCND1—sarcoma	8.99e-07	0.000218	CbGpPWpGaD
Bromocriptine—HTR1D—Signaling Pathways—KRAS—sarcoma	8.97e-07	0.000217	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—JUN—sarcoma	8.97e-07	0.000217	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—IL2—sarcoma	8.97e-07	0.000217	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—MDM2—sarcoma	8.96e-07	0.000217	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—CTNNB1—sarcoma	8.94e-07	0.000217	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling Pathways—MYC—sarcoma	8.93e-07	0.000216	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—NRAS—sarcoma	8.92e-07	0.000216	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—NRAS—sarcoma	8.92e-07	0.000216	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling by GPCR—KRAS—sarcoma	8.91e-07	0.000216	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—CTNNB1—sarcoma	8.9e-07	0.000215	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—IL2—sarcoma	8.82e-07	0.000214	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling Pathways—KRAS—sarcoma	8.79e-07	0.000213	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—MDM2—sarcoma	8.77e-07	0.000212	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—CCND1—sarcoma	8.74e-07	0.000212	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling Pathways—EGFR—sarcoma	8.74e-07	0.000212	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—JUN—sarcoma	8.72e-07	0.000211	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—CTNNB1—sarcoma	8.65e-07	0.00021	CbGpPWpGaD
Bromocriptine—DRD4—Signaling Pathways—KRAS—sarcoma	8.65e-07	0.000209	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—CCND1—sarcoma	8.6e-07	0.000208	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—JUN—sarcoma	8.58e-07	0.000208	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—CTNNB1—sarcoma	8.52e-07	0.000206	CbGpPWpGaD
Bromocriptine—DRD2—Signaling by GPCR—HRAS—sarcoma	8.46e-07	0.000205	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—SRC—sarcoma	8.45e-07	0.000205	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—MYC—sarcoma	8.42e-07	0.000204	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—SRC—sarcoma	8.37e-07	0.000203	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling by GPCR—HRAS—sarcoma	8.32e-07	0.000202	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—MYC—sarcoma	8.31e-07	0.000201	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—MYC—sarcoma	8.31e-07	0.000201	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling Pathways—KRAS—sarcoma	8.25e-07	0.0002	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—EGFR—sarcoma	8.24e-07	0.0002	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—VEGFA—sarcoma	8.23e-07	0.000199	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—VEGFA—sarcoma	8.16e-07	0.000198	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—MDM2—sarcoma	8.15e-07	0.000197	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling by GPCR—HRAS—sarcoma	8.15e-07	0.000197	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—IL2—sarcoma	8.13e-07	0.000197	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—NRAS—sarcoma	8.13e-07	0.000197	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—EGFR—sarcoma	8.13e-07	0.000197	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—EGFR—sarcoma	8.13e-07	0.000197	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—SRC—sarcoma	8.08e-07	0.000196	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—NRAS—sarcoma	8.06e-07	0.000195	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—SRC—sarcoma	8.04e-07	0.000195	CbGpPWpGaD
Bromocriptine—HTR6—Signaling Pathways—TP53—sarcoma	8.04e-07	0.000195	CbGpPWpGaD
Bromocriptine—HTR7—Signaling Pathways—TP53—sarcoma	8.03e-07	0.000194	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—IL2—sarcoma	8e-07	0.000194	CbGpPWpGaD
Bromocriptine—HTR1D—Signaling Pathways—TP53—sarcoma	7.98e-07	0.000193	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—CCND1—sarcoma	7.93e-07	0.000192	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—JUN—sarcoma	7.91e-07	0.000192	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—VEGFA—sarcoma	7.87e-07	0.000191	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—CTNNB1—sarcoma	7.85e-07	0.00019	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—IL2—sarcoma	7.84e-07	0.00019	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—VEGFA—sarcoma	7.83e-07	0.00019	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—SRC—sarcoma	7.82e-07	0.000189	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling Pathways—TP53—sarcoma	7.81e-07	0.000189	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—CCND1—sarcoma	7.8e-07	0.000189	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—JUN—sarcoma	7.79e-07	0.000189	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—KRAS—sarcoma	7.78e-07	0.000189	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—NRAS—sarcoma	7.78e-07	0.000188	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—NRAS—sarcoma	7.74e-07	0.000187	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—CTNNB1—sarcoma	7.73e-07	0.000187	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—SRC—sarcoma	7.7e-07	0.000186	CbGpPWpGaD
Bromocriptine—HTR6—Signaling Pathways—HRAS—sarcoma	7.69e-07	0.000186	CbGpPWpGaD
Bromocriptine—DRD4—Signaling Pathways—TP53—sarcoma	7.69e-07	0.000186	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—KRAS—sarcoma	7.68e-07	0.000186	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—KRAS—sarcoma	7.68e-07	0.000186	CbGpPWpGaD
Bromocriptine—HTR7—Signaling Pathways—HRAS—sarcoma	7.68e-07	0.000186	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—CCND1—sarcoma	7.64e-07	0.000185	CbGpPWpGaD
Bromocriptine—HTR1D—Signaling Pathways—HRAS—sarcoma	7.63e-07	0.000185	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—JUN—sarcoma	7.62e-07	0.000185	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—VEGFA—sarcoma	7.62e-07	0.000185	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—MYC—sarcoma	7.57e-07	0.000183	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling by GPCR—HRAS—sarcoma	7.57e-07	0.000183	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—CTNNB1—sarcoma	7.57e-07	0.000183	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—NRAS—sarcoma	7.53e-07	0.000182	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—MYC—sarcoma	7.5e-07	0.000182	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—VEGFA—sarcoma	7.5e-07	0.000182	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling Pathways—HRAS—sarcoma	7.47e-07	0.000181	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—EGFR—sarcoma	7.41e-07	0.000179	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—NRAS—sarcoma	7.41e-07	0.000179	CbGpPWpGaD
Bromocriptine—DRD4—Signaling Pathways—HRAS—sarcoma	7.35e-07	0.000178	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—EGFR—sarcoma	7.34e-07	0.000178	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling Pathways—TP53—sarcoma	7.34e-07	0.000178	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—IL2—sarcoma	7.28e-07	0.000176	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—MYC—sarcoma	7.24e-07	0.000175	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—MYC—sarcoma	7.21e-07	0.000175	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—CCND1—sarcoma	7.1e-07	0.000172	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—SRC—sarcoma	7.1e-07	0.000172	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—EGFR—sarcoma	7.09e-07	0.000172	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—JUN—sarcoma	7.08e-07	0.000172	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—EGFR—sarcoma	7.05e-07	0.000171	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—CTNNB1—sarcoma	7.03e-07	0.00017	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling Pathways—HRAS—sarcoma	7.02e-07	0.00017	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—MYC—sarcoma	7.01e-07	0.00017	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—KRAS—sarcoma	7e-07	0.000169	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—SRC—sarcoma	6.98e-07	0.000169	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—KRAS—sarcoma	6.93e-07	0.000168	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—TP53—sarcoma	6.92e-07	0.000168	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—VEGFA—sarcoma	6.91e-07	0.000167	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—MYC—sarcoma	6.9e-07	0.000167	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—EGFR—sarcoma	6.86e-07	0.000166	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—SRC—sarcoma	6.84e-07	0.000166	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—NRAS—sarcoma	6.83e-07	0.000165	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—TP53—sarcoma	6.83e-07	0.000165	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—TP53—sarcoma	6.83e-07	0.000165	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—VEGFA—sarcoma	6.8e-07	0.000165	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—EGFR—sarcoma	6.75e-07	0.000163	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—NRAS—sarcoma	6.72e-07	0.000163	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—KRAS—sarcoma	6.69e-07	0.000162	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—VEGFA—sarcoma	6.66e-07	0.000161	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—KRAS—sarcoma	6.66e-07	0.000161	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—HRAS—sarcoma	6.62e-07	0.00016	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—NRAS—sarcoma	6.58e-07	0.000159	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—HRAS—sarcoma	6.53e-07	0.000158	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—HRAS—sarcoma	6.53e-07	0.000158	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—KRAS—sarcoma	6.48e-07	0.000157	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—KRAS—sarcoma	6.37e-07	0.000154	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—MYC—sarcoma	6.36e-07	0.000154	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—SRC—sarcoma	6.35e-07	0.000154	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—MYC—sarcoma	6.26e-07	0.000152	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—EGFR—sarcoma	6.22e-07	0.000151	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—TP53—sarcoma	6.22e-07	0.000151	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—VEGFA—sarcoma	6.19e-07	0.00015	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—TP53—sarcoma	6.16e-07	0.000149	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—MYC—sarcoma	6.13e-07	0.000148	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—EGFR—sarcoma	6.12e-07	0.000148	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—NRAS—sarcoma	6.11e-07	0.000148	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—EGFR—sarcoma	5.99e-07	0.000145	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—TP53—sarcoma	5.95e-07	0.000144	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—HRAS—sarcoma	5.95e-07	0.000144	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—TP53—sarcoma	5.92e-07	0.000143	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—HRAS—sarcoma	5.89e-07	0.000143	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—KRAS—sarcoma	5.88e-07	0.000142	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—KRAS—sarcoma	5.78e-07	0.00014	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—TP53—sarcoma	5.76e-07	0.000139	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—MYC—sarcoma	5.69e-07	0.000138	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—HRAS—sarcoma	5.69e-07	0.000138	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—TP53—sarcoma	5.67e-07	0.000137	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—KRAS—sarcoma	5.66e-07	0.000137	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—HRAS—sarcoma	5.66e-07	0.000137	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—EGFR—sarcoma	5.57e-07	0.000135	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—HRAS—sarcoma	5.51e-07	0.000133	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—HRAS—sarcoma	5.42e-07	0.000131	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—KRAS—sarcoma	5.26e-07	0.000127	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—TP53—sarcoma	5.22e-07	0.000127	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—TP53—sarcoma	5.14e-07	0.000124	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—TP53—sarcoma	5.03e-07	0.000122	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—HRAS—sarcoma	5e-07	0.000121	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—HRAS—sarcoma	4.92e-07	0.000119	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—HRAS—sarcoma	4.81e-07	0.000117	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—TP53—sarcoma	4.68e-07	0.000113	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—HRAS—sarcoma	4.47e-07	0.000108	CbGpPWpGaD
